Frailty Status and Mortality Risk in PCI; Delays in Treatment in STEMI; Arterial Events with Genetic-based Vascular Disease
In this week’s View, Dr. Eagle looks at frailty status and increased risk of mortality in patients who undergo percutaneous coronary intervention (PCI). He then discusses the timely treatment and delays in treatment of ST-segment elevation myocardial infarction (STEMI) that are associated with worse outcomes. Finally, Dr. Eagle explores new insights on arterial events associated with heritable thoracic aortic disease and the relative risk in patients with pathogenic variants, as well as the prevalence, characteristics, and clinical outcomes of arterial aneurysms in Loeys-Dietz Syndrome.
X Links:
- Kim Eagle, MD, MACC keaglemd
Clinical Topics: Acute Coronary Syndromes, Cardiac Surgery, Cardiovascular Care Team, Congenital Heart Disease and Pediatric Cardiology, Invasive Cardiovascular Angiography and Intervention, Vascular Medicine, Aortic Surgery, Cardiac Surgery and CHD and Pediatrics, Congenital Heart Disease, CHD and Pediatrics and Interventions, Interventions and ACS, Interventions and Structural Heart Disease, Interventions and Vascular Medicine
Keywords: National Cardiovascular Data Registries, CathPCI Registry, Frailty, Percutaneous Coronary Intervention, Hospital Mortality, Acute Coronary Syndrome, Myocardial Ischemia, Emergency Medicine, Loeys-Dietz Syndrome, Marfan Syndrome, Ehlers-Danlos Syndrome, Thoracic Diseases, Aortic Aneurysm, Thoracic, EaglesEyeView
